This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DSM-Firmenich Future Growth

Future criteria checks 4/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for DSM-Firmenich.

Key information

20.5%

Earnings growth rate

18.3%

EPS growth rate

Chemicals earnings growth	20.2%
Revenue growth rate	11.1%
Future return on equity	n/a
Analyst coverage	Good
Last updated	16 May 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:RDSM - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	14,665	1,015	749	1,913	8
12/31/2024	13,934	687	847	1,913	9
12/31/2023	12,024	546	344	1,084	9
12/31/2022	8,390	454	314	965	N/A
9/30/2022	9,582	837	412	1,056	N/A
6/30/2022	9,802	1,082	510	1,147	N/A
3/31/2022	9,503	1,081	680	1,287	N/A
12/31/2021	7,269	820	850	1,427	N/A
9/30/2021	7,955	660	884	1,507	N/A
6/30/2021	7,558	493	906	1,489	N/A
3/31/2021	7,572	423	906	1,497	N/A
12/31/2020	8,106	448	868	1,494	N/A
9/30/2020	7,960	510	809	1,434	N/A
6/30/2020	8,034	557	810	1,462	N/A
3/31/2020	9,011	722	826	1,471	N/A
12/31/2019	7,998	675	744	1,385	N/A
9/30/2019	8,272	820	766	1,399	N/A
6/30/2019	8,502	794	747	1,395	N/A
3/31/2019	9,124	934	612	1,282	N/A
12/31/2018	9,267	1,069	698	1,391	N/A
9/30/2018	9,235	984	657	1,310	N/A
6/30/2018	9,106	2,082	550	1,170	N/A
3/31/2018	8,908	1,942	512	1,110	N/A
12/31/2017	8,632	1,761	441	996	N/A
9/30/2017	8,471	1,676	431	993	N/A
6/30/2017	8,333	738	470	1,028	N/A
3/31/2017	8,166	711	554	1,077	N/A
12/31/2016	7,920	645	523	1,018	N/A
9/30/2016	7,831	588	N/A	958	N/A
6/30/2016	7,778	274	N/A	914	N/A
3/31/2016	7,749	214	N/A	811	N/A
12/31/2015	7,722	174	N/A	696	N/A
9/30/2015	7,607	66	N/A	800	N/A
6/30/2015	7,456	114	N/A	820	N/A
3/31/2015	7,245	115	N/A	867	N/A
12/31/2014	7,051	123	N/A	808	N/A
9/30/2014	7,415	112	N/A	866	N/A
6/30/2014	7,834	138	N/A	885	N/A
3/31/2014	8,362	182	N/A	1,010	N/A
12/31/2013	8,858	252	N/A	998	N/A
9/30/2013	8,409	363	N/A	705	N/A
6/30/2013	8,500	335	N/A	638	N/A
3/31/2013	8,486	257	N/A	584	N/A
12/31/2012	8,588	280	N/A	730	N/A
9/30/2012	9,089	453	N/A	950	N/A
6/30/2012	9,107	543	N/A	1,020	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RDSM's forecast earnings growth (20.5% per year) is above the savings rate (0.6%).

Earnings vs Market: RDSM's earnings (20.5% per year) are forecast to grow faster than the Austrian market (5.4% per year).

High Growth Earnings: RDSM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: RDSM's revenue (11.1% per year) is forecast to grow faster than the Austrian market (-3.4% per year).

High Growth Revenue: RDSM's revenue (11.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if RDSM's Return on Equity is forecast to be high in 3 years time

Discover growth companies


Price	7D	1Y
Mkt Cap	P/E	Growth


Price	7D	1Y
Mkt Cap	P/E	Growth


Price	7D	1Y
Mkt Cap	P/E	Growth


Price	7D	1Y
Mkt Cap	P/E	Growth

This company listing is no longer active

DSM-Firmenich Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Koninklijke DSM N.V. Reaffirms Earnings Guidance for the Year 2022

DSM Suspends Overall Earnings Outlook for the Full Year 2020

Recent updates

DSM-Firmenich AG has completed a Follow-on Equity Offering in the amount of €733.264232 million.

Key Executive recently sold €438k worth of stock

Full year 2022 earnings released: EPS: €2.63 (vs €4.75 in FY 2021)

Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)

DSM Firmenich Announces Intention Pay Final Gross Dividend

Key Executive recently bought €587k worth of stock

Royal DSM NV Sponsored ADR to Be Deleted from OTC Equity

Investor sentiment improved over the past week

Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023

Avient Corporation (NYSE:AVNT) completed the acquisition of Protective Materials business of Koninklijke DSM N.V. (ENXTAM:DSM)

First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)

Koninklijke DSM N.V. Announces Interim Dividend

Koninklijke DSM N.V. (ENXTAM:DSM) agrees to acquire Prodap Participacoes S/A.

Advent International Corporation and LANXESS Aktiengesellschaft (XTRA:LXS) agreed to acquire Engineering Materials business of Royal DSM from Koninklijke DSM N.V. (ENXTAM:DSM) for €3.9 billion.

Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 June 2022

Public Joint Stock Company KuibyshevAzot (MISX:KAZT) acquired Volgaplast Compounding Ltd from Koninklijke DSM N.V. (ENXTAM:DSM) for RUB119 million.

Upcoming dividend of €1.70 per share

Koninklijke DSM N.V. Reaffirms Earnings Guidance for the Year 2022

Avient Corporation (NYSE:AVNT) entered into agreement to acquire Protective Materials business of Koninklijke DSM N.V. (ENXTAM:DSM) for €1.4 billion ($1.5 billion).

Avient Corporation (NYSE:AVNT) eneteed into agreement to acquire Protective Materials business of DSM

DSM receives landmark EU market approval for its methane-reducing feed additive Bovaer

Royal DSM Proposes Dividend Increase

Lanxess Reportedly Teams Up with Advent to Bid for DSM's Materials Ops

Koninklijke DSM N.V. (ENXTAM:DSM) completed the acquisition of Vestkorn Milling AS.

Koninklijke DSM N.V. (ENXTAM:DSM) signed an agreement to acquire Vestkorn Milling As for an enterprise value of €65 million.

Koninklijke DSM N.V. Receives First Full Market Authorizations for Methane-Reducing Feed Additive Bovaer® for Beef and Dairy in Brazil and Chile

Independent Deputy Chairwoman of Supervisory Board has left the company

Independent Chairman of Supervisory Board Robert Routs has left the company

Royal DSM Declares Final Dividend for the Financial Year 2020, Payable from 1 June 2021

Upcoming dividend of €1.60 per share

Key Executive recently sold €750k worth of stock

Worthen Industries, Inc. agreed to acquire Advanced Solar Backsheets Business of Koninklijke DSM N.V. from Koninklijke DSM N.V. (ENXTAM:DSM).

Koninklijke Dsm N.V. Announces Board Changes

Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)

Revenue misses expectations

Royal DSM Announces Executive Changes

Valio and Royal Dsm Announces Collaboration Agreement to Develop Sustainable Dairy Products

DSM Suspends Overall Earnings Outlook for the Full Year 2020

Koninklijke DSM N.V. (ENXTAM:DSM) completed the acquisition of ERBER Group from Erber It Service GmbH, San Pacific Investments Pte Ltd. and San Venture Pte. ltd.

Covestro AG (XTRA:1COV) reached an agreement to acquire Resins & Functional Materials and associated businesses from Koninklijke DSM N.V. (ENXTAM:DSM) for purchase price of €1.6 billion.

New 90-day high: €141

Würth Industry North America Signs Agreement with DSM To Nationally Distribute DSM 3D Printing Material Solutions

New 90-day high - €137

New 90-day high - €134

First half earnings released

Koninklijke DSM N.V. to Report Q1, 2021 Results on May 05, 2021

Koninklijke DSM N.V. completed the acquisition of 100% stake in Pocketcoach GmbH.

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies